ABT vs ADP · P/E 25, rev $44.33B vs P/E 20, rev $21.95B
Abbott Laboratories (ABT) versus Automatic Data Processing Inc (ADP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Automatic Data Processing Inc (ADP) is a software - application company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported ADP revenue for 2026-06-30 was $21.95B. Net income was $4.41B. Revenue was up 6.7% from 2025-06-30 to 2026-06-30. ADP currently screens at market cap $87.45B and trailing P/E 20.4.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. ADP currently screens at market cap $87.45B and trailing P/E 20.4.
Not investment advice. Open the ABT and ADP stock pages for the full models.
Not investment advice.